Results 201 to 210 of about 707,608 (244)

Engineering tandem VHHs to target different epitopes to enhance antibody‐dependent cell‐mediated cytotoxicity

open access: yesFEBS Open Bio, EarlyView.
Tandem VHH targeting distinct EGFR epitopes were engineered into a monovalent bispecific antibody (7D12‐EGA1‐Fc) with more potent ADCC without increasing affinity to EGFR. Structural modeling of 7D12‐EGA1‐Fc showed cross‐linking of separate EGFR domains to enhance CD16a engagement on NK cells.
Yuqiang Xu   +5 more
wiley   +1 more source

A short-term price prediction-based trading strategy. [PDF]

open access: yesPLoS One
Fan W, Zhang R, He H, Hou S, Tan Y.
europepmc   +1 more source

Home - About - Disclaimer - Privacy